Division of Plastic and Reconstructive Surgery, Department of Surgery, McGill University, Montreal, Quebec, Canada.
Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
J Reconstr Microsurg. 2022 Sep;38(7):539-548. doi: 10.1055/s-0041-1740132. Epub 2021 Dec 7.
Vascularized lymph node transfers (VLNT) are being used with increasing frequency for the treatment of breast cancer-related lymphedema (BCRL). However, there is a lack of consensus in the surgical field as to which recipient site should be utilized. We, therefore, aim to assess the evidence comparing the wrist and axilla as recipient sites for VLNT in BCRL.
We conducted a systematic literature review to compare the wrist and axilla as recipient sites for VLNT in BCRL. Demographic data, as well as circumference reduction rate (CRR), excess volume reduction (EVR), postoperative decrease in infections per year, postoperative discontinuation of compression garments, and overall pooled complication rate were extracted from included studies. These were compared through a meta-analysis.
A total of 37 studies met the inclusion criteria for a total of 689 patients. VLNTs to the wrist and axilla resulted in a decrease in CRR of 42.1 and 51.5%, and a decrease in EVR of 35.6 and 48.8%, respectively. However, our meta-analysis showed no significant differences between CRR or EVR and between wrist and axilla as recipient sites. Similarly, we found no differences in postoperative decrease in infections per year, postoperative discontinuation of compression garments, and overall pooled complication rate.
These data suggest noninferiority between the wrist and axilla as recipient sites for VLNT in the context of BCRL. In the absence of randomized, prospective data, we hope these results can be used as an evidence-based reference and facilitate future studies.
带血管化淋巴结转移(VLNT)越来越多地用于治疗乳腺癌相关淋巴水肿(BCRL)。然而,在手术领域,对于应该使用哪个受体部位,尚未达成共识。因此,我们旨在评估比较腕部和腋窝作为 BCRL 中 VLNT 受体部位的证据。
我们进行了一项系统的文献综述,以比较腕部和腋窝作为 BCRL 中 VLNT 的受体部位。从纳入的研究中提取了人口统计学数据,以及周长减少率(CRR)、多余体积减少率(EVR)、每年术后感染减少量、术后停止使用压缩衣和总体汇总并发症发生率。通过荟萃分析比较了这些数据。
共有 37 项研究符合纳入标准,共 689 名患者。VLNT 至腕部和腋窝分别导致 CRR 降低 42.1%和 51.5%,EVR 降低 35.6%和 48.8%。然而,我们的荟萃分析表明,CRR 或 EVR 以及腕部和腋窝作为受体部位之间没有显著差异。同样,我们发现每年术后感染减少量、术后停止使用压缩衣和总体汇总并发症发生率没有差异。
这些数据表明,在 BCRL 背景下,VLNT 的腕部和腋窝受体部位之间具有非劣效性。在缺乏随机、前瞻性数据的情况下,我们希望这些结果可以作为循证参考,并促进未来的研究。